Physician profile
Abram S Arnold
NPI 1659892511
$838.35
in general payments reported to CMS, 2019-2025
10 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.32 · 2020: $95.03 · 2022: $292 · 2023: $122 · 2024: $69.99 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $347 · Food and Beverage: $38.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $346.96 |
| Food and Beverage | $38.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $183.98 | 2023-2025 | Venclexta |
| Novo Nordisk INC | $128.14 | 2019-2020 | |
| Amgen INC. | $124.94 | 2022 | |
| Alnylam Pharmaceuticals INC. | $124.94 | 2022 | |
| Incyte Corporation | $92.99 | 2025 | |
| Astellas Pharma US INC | $90.61 | 2023-2024 | Xospata |
| Janssen Pharmaceuticals, INC | $41.70 | 2022 | |
| Teleflex LLC | $17.84 | 2023 | Arrow |
| Mylan Specialty L.P. | $16.89 | 2020 | |
| Merck Sharp & Dohme LLC | $16.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abram Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.